SA competition watchdog probes Novo Nordisk and Sanofi over insulin
South Africa's Competition Commission is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive practices in the human insulin pen market, the authority said on Tuesday, 4 March.
Image source: pikisuperstar from Freepik
"We are currently engaging with market participants," a spokesperson for the commission told Reuters, declining to provide details.
The news was reported earlier on Tuesday by Bloomberg.
Novo Nordisk and Sanofi are two of the world's largest makers of insulin.
While Sanofi did not immediately respond to a request for comment, Novo Nordisk told Reuters in a statement it welcomed the opportunity to provide information and would cooperate fully with authorities.
The company decided not to participate in the 2024 tender for human insulin pens in South Africa and instead tendered for insulin vials, it said.
"We ensured that the public sector had adequate access to insulin through this route," it added.
In November last year, Novo Nordisk told Reuters that it was phasing out production of human insulin pens, as it spends billions to increase manufacturing of its popular obesity and diabetes injections.
Related
Google, Meta face penalties for anti-competitive behaviour towards SA news media Nqobile Dludla 24 Feb 2025 From Singapore to the world: Sanofi's new plant eyes global vaccine challenges Katja Hamilton 27 Nov 2024 Urgent warning as fake Ozempic infiltrates South African market 11 Nov 2024 Nedbank Top Empowerment Conference 2024: A call to action for South Africa's inclusive transformationTopco Media 28 Aug 2024 Sanofi commits to affordable insulin pens for diabetic patients 20 Aug 2024 Forget chat bots, AI is helping out in drug discovery and development Lindsey Schutters 17 Jul 2024 Biotts makes history: Transdermal insulin delivery 2 May 2024 The rise of Ozempic: how surprise discoveries and lizard venom led to a new class of weight-loss drugs 11 Apr 2024
Source: Reuters
Reuters, the news and media division of Thomson Reuters, is the world's largest multimedia news provider, reaching billions of people worldwide every day.
Go to: https://www.reuters.com/About Maggie Fick and Nqobile Dludla
Reporting by Maggie Fick in London and Nqobile Dludla in Johannesburg; editing by Barbara Lewis
